文献速递心脑血管急症重症综合管理与镇静镇痛

基于脑脊液的容积影像学生物标志物揭示缺血性卒中后脑水肿的发生率与危险因素

CSF-Based Volumetric Imaging Biomarkers Highlight Incidence and Risk Factors for Cerebral Edema After Ischemic Stroke.
PubMed 文献 · Neurocrit Care · 2023-05-15
一句话结论脑脊液位移ΔCSF>14%或CSF比值<0.90可在超过半数卒中患者中识别脑水肿,且与90天不良预后独立相关(每21% ΔCSF OR 1.7)。

本研究对935例大脑半球卒中患者在中位26小时(四分位距24-31)复查CT,用自动图像分析流程测量脑脊液位移(ΔCSF)和病灶侧与对侧半球脑脊液容积比值(CSF比值)。ΔCSF>14%或CSF比值<0.90可识别可见水肿,超过半数患者符合,而24小时有中线移位者仅14%。ΔCSF和较低CSF比值均与更差预后相关,校正年龄、NIHSS评分和ASPECTS后,每21% ΔCSF的OR为1.7(95%CI 1.3-2.2)。

要点

  • ΔCSF>14%或CSF比值<0.90为可见水肿的诊断阈值,超过半数卒中患者符合,而24小时有中线移位者仅14%。
  • ΔCSF与中线移位相关(r=0.52),CSF比值与中线移位相关(r=-0.74),但二者范围更宽。
  • ΔCSF和较低CSF比值均与90天更差预后相关,校正年龄、NIHSS评分和ASPECTS后,每21% ΔCSF的OR为1.7(95%CI 1.3-2.2)。
  • 所有生物标志物预测水肿的因素包括更高的NIHSS评分、更低的ASPECTS和更低的基线CSF容积。
  • 高血压和糖尿病病史(而非急性高血糖)预测更大的ΔCSF,但不预测中线移位。

适用人群与场景

  • 935例大脑半球卒中患者,于卒中 onset 后中位26小时(四分位距24-31)行复查CT。

诊断标准与关键阈值

  • ΔCSF>14%或CSF比值<0.90可识别可见水肿(基于与无可见水肿者的比较确定)。

研究设计与关键结果

  • 研究类型:队列研究;样本量935例;人群:大脑半球卒中患者;干预/方法:自动图像分析流程测量ΔCSF和CSF比值,中位26小时(四分位距24-31)复查CT。
  • ΔCSF与中线移位相关(r=0.52,p<0.0001),CSF比值与中线移位相关(r=-0.74,p<0.0001),但二者范围更宽。
  • ΔCSF>14%或CSF比值<0.90识别可见水肿:超过半数卒中患者符合,而24小时有中线移位者仅14%。
  • 所有生物标志物预测水肿的因素包括更高的NIHSS评分、更低的ASPECTS和更低的基线CSF容积;高血压和糖尿病病史(而非急性高血糖)预测更大的ΔCSF但不预测中线移位。
  • ΔCSF和较低CSF比值均与更差预后(90天改良Rankin量表)相关,校正年龄、NIHSS评分和ASPECTS后,每21% ΔCSF的OR为1.7(95%CI 1.3-2.2)。

证据类型、等级与局限

  • 证据类型:队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于脑脊液的容积生物标志物可在多数卒中患者复查CT时测量脑水肿,包括许多无可见中线移位者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cerebral edema has primarily been studied using midline shift or clinical deterioration as end points, which only captures the severe and delayed manifestations of a process affecting many patients with stroke. Quantitative imaging biomarkers that measure edema severity across the entire spectrum could improve its early detection, as well as identify relevant mediators of this important stroke complication.

METHODS: We applied an automated image analysis pipeline to measure the displacement of cerebrospinal fluid (ΔCSF) and the ratio of lesional versus contralateral hemispheric cerebrospinal fluid (CSF) volume (CSF ratio) in a cohort of 935 patients with hemispheric stroke with follow-up computed tomography scans taken a median of 26 h (interquartile range 24-31) after stroke onset. We determined diagnostic thresholds based on comparison to those without any visible edema. We modeled baseline clinical and radiographic variables against each edema biomarker and assessed how each biomarker was associated with stroke outcome (modified Rankin Scale at 90 days).

RESULTS: The displacement of CSF and CSF ratio were correlated with midline shift (r = 0.52 and - 0.74, p < 0.0001) but exhibited broader ranges. A ΔCSF of greater than 14% or a CSF ratio below 0.90 identified those with visible edema: more than half of the patients with stroke met these criteria, compared with only 14% who had midline shift at 24 h. Predictors of edema across all biomarkers included a higher National Institutes of Health Stroke Scale score, a lower Alberta Stroke Program Early CT score, and lower baseline CSF volume. A history of hypertension and diabetes (but not acute hyperglycemia) predicted greater ΔCSF but not midline shift. Both ΔCSF and a lower CSF ratio were associated with worse outcome, adjusting for age, National Institutes of Health Stroke Scale score, and Alberta Stroke Program Early CT score (odds ratio 1.7, 95% confidence interval 1.3-2.2 per 21% ΔCSF).

CONCLUSIONS: Cerebral edema can be measured in a majority of patients with stroke on follow-up computed tomography using volumetric biomarkers evaluating CSF shifts, including in many without visible midline shift. Edema formation is influenced by clinical and radiographic stroke severity but also by chronic vascular risk factors and contributes to worse stroke outcomes.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Bui Q, Kumar A, Chen Y, et al. CSF-Based Volumetric Imaging Biomarkers Highlight Incidence and Risk Factors for Cerebral Edema After Ischemic Stroke. Neurocrit Care. 2023. PMID: 37188885. doi:10.1007/s12028-023-01742-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。